Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.365 USD | -0.46% |
|
+6.66% | +47.39% |
Jun. 22 | MannKind Corporation Announces Positive 17-Week Results from the INHALE-3 Study | CI |
May. 29 | MannKind Agrees to Cross License Deal With Pulmatrix | MT |
Evolution of the average Target Price on MannKind Corporation
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
![Consensus](/images/consensus_flch.gif)
Consensus detail
Consensus revision (last 18 months)
Analysts covering MannKind Corporation
Oppenheimer | |
Wedbush | |
HC Wainwright | |
SVB Securities LLC | |
RBC Capital Markets | |
SVB Leerink |
EPS Revisions
- Stock Market
- Equities
- MNKD Stock
- Consensus MannKind Corporation